Share Price and Basic Stock Data
Last Updated: December 29, 2025, 4:45 pm
| PEG Ratio | -2.75 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Black Rose Industries Ltd operates in the specialty chemicals sector, focusing on high-value applications. The company’s stock price stood at ₹96.1, with a market capitalization of ₹490 Cr. Over recent years, Black Rose Industries has experienced fluctuations in revenue, with reported sales of ₹430 Cr in FY 2023, a decline from ₹488 Cr in FY 2022. However, the company has shown resilience, with TTM revenue reported at ₹313 Cr. Quarterly sales have varied, peaking at ₹115.36 Cr in Mar 2024 and declining to ₹83.86 Cr in Sep 2023. This pattern indicates a cyclical nature in demand, possibly influenced by external market conditions. The company’s operating profit margin (OPM) has also fluctuated, recorded at 8.59% currently, reflecting the challenges and opportunities in the specialty chemicals market. Overall, while revenue has faced pressures, the strategic positioning in the specialty chemicals domain remains a focal point for potential recovery and growth.
Profitability and Efficiency Metrics
Profitability metrics for Black Rose Industries indicate a mixed performance. The company reported a net profit of ₹20 Cr for the latest financial year, translating to a P/E ratio of 24.1, which is relatively high compared to industry norms, suggesting investor optimism. The return on equity (ROE) stood at 14.2%, while the return on capital employed (ROCE) was at 19.0%, indicating effective utilization of capital. Operating profit margins have shown improvement, rising to 8.59%, which is above the lower end of typical sector ranges. However, the cash conversion cycle (CCC) extended to 99 days, suggesting potential inefficiencies in working capital management. This could impact liquidity if not managed effectively. The interest coverage ratio (ICR) at 32.70x indicates strong ability to cover interest obligations, providing a buffer against financial distress. These profitability and efficiency metrics highlight both the strengths and areas needing improvement in the company’s operational framework.
Balance Sheet Strength and Financial Ratios
Black Rose Industries maintains a balanced financial position, with total assets reported at ₹214 Cr and total liabilities at ₹214 Cr, reflecting a debt-free stance, as borrowings stood at just ₹8 Cr. The company has accumulated reserves of ₹150 Cr, which supports its equity base and future growth endeavors. The price-to-book value (P/BV) ratio of 2.98x suggests that the market values the stock at a premium compared to its book value, indicating investor confidence. The current ratio is reported at 2.97, well above the typical threshold of 1, indicating robust liquidity. However, the inventory turnover ratio has declined to 7.12, which may raise concerns about inventory management efficiency. Additionally, the dividend payout ratio has surged to 64.52%, reflecting a commitment to returning capital to shareholders, but may limit reinvestment opportunities. Overall, the balance sheet reveals a solid foundation, albeit with certain efficiency challenges that need addressing.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Black Rose Industries showcases a strong promoter commitment, with promoters holding 75.00% of the equity, signaling confidence from the founding members. The public shareholding stands at 24.94%, with foreign institutional investors (FIIs) not holding any stake, and domestic institutional investors (DIIs) having a minimal presence at 0.07%. The total number of shareholders has decreased from 79,251 in Dec 2022 to 52,795 in Sep 2025, indicating a potential consolidation of ownership or reduced retail participation. This decline in shareholder numbers could reflect market sentiment or investor fatigue. The high promoter holding is a positive indicator of stability and long-term commitment, but the lack of institutional support may pose risks in terms of stock volatility and market perception. The concentration of ownership could lead to challenges in governance and decision-making processes, necessitating a balanced approach to stakeholder engagement.
Outlook, Risks, and Final Insight
Looking ahead, Black Rose Industries faces both opportunities and challenges. The ongoing demand for specialty chemicals presents growth potential, particularly if the company can enhance its operational efficiencies and better manage its cash conversion cycle. However, the fluctuating revenue and profit margins pose risks, particularly in a competitive market landscape. External factors such as raw material price volatility and regulatory changes in the chemicals sector could further impact profitability. The company’s strong balance sheet and high interest coverage ratio provide a safety net against financial distress, yet reliance on a concentrated promoter holding raises governance concerns. In scenarios of improved operational execution and market stabilization, the company could enhance its profitability metrics. Conversely, continued revenue decline without strategic interventions may lead to further erosion of shareholder confidence. The path forward will require careful navigation of operational challenges and market dynamics to leverage growth opportunities effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 390 Cr. | 42.5 | 83.5/41.2 | 24.3 | 20.5 | 0.94 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 31.4 Cr. | 64.0 | 88.8/56.0 | 15.0 | 89.6 | 1.56 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 48.2 Cr. | 709 | 932/600 | 22.2 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,371 Cr. | 74.3 | 111/74.0 | 22.3 | 22.0 | 0.67 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 633 Cr. | 254 | 393/230 | 22.7 | 93.8 | 0.99 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,774.80 Cr | 721.01 | 68.60 | 183.02 | 0.44% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 101.94 | 97.50 | 111.17 | 87.62 | 83.86 | 93.62 | 115.36 | 98.27 | 93.05 | 86.71 | 82.89 | 59.85 | 83.98 |
| Expenses | 98.76 | 96.32 | 108.13 | 81.99 | 75.87 | 86.34 | 108.20 | 92.09 | 86.44 | 78.90 | 74.36 | 53.99 | 76.77 |
| Operating Profit | 3.18 | 1.18 | 3.04 | 5.63 | 7.99 | 7.28 | 7.16 | 6.18 | 6.61 | 7.81 | 8.53 | 5.86 | 7.21 |
| OPM % | 3.12% | 1.21% | 2.73% | 6.43% | 9.53% | 7.78% | 6.21% | 6.29% | 7.10% | 9.01% | 10.29% | 9.79% | 8.59% |
| Other Income | 0.43 | 0.52 | 0.79 | 0.74 | 1.09 | 1.09 | 1.67 | 1.04 | 0.88 | 0.96 | 0.43 | 0.99 | 0.33 |
| Interest | 0.63 | 0.51 | 0.48 | 0.19 | 0.25 | 0.19 | 0.44 | 0.07 | 0.23 | 0.30 | 0.39 | 0.21 | 0.51 |
| Depreciation | 0.79 | 0.78 | 0.79 | 0.76 | 0.73 | 0.77 | 0.75 | 0.78 | 0.79 | 0.79 | 0.78 | 0.90 | 0.95 |
| Profit before tax | 2.19 | 0.41 | 2.56 | 5.42 | 8.10 | 7.41 | 7.64 | 6.37 | 6.47 | 7.68 | 7.79 | 5.74 | 6.08 |
| Tax % | 29.22% | 34.15% | 29.30% | 25.28% | 25.43% | 26.59% | 25.52% | 25.90% | 27.20% | 25.65% | 25.29% | 27.00% | 27.30% |
| Net Profit | 1.55 | 0.27 | 1.81 | 4.05 | 6.04 | 5.44 | 5.70 | 4.72 | 4.71 | 5.70 | 5.81 | 4.19 | 4.43 |
| EPS in Rs | 0.30 | 0.05 | 0.35 | 0.79 | 1.18 | 1.07 | 1.12 | 0.93 | 0.92 | 1.12 | 1.14 | 0.82 | 0.87 |
Last Updated: December 27, 2025, 6:38 pm
Below is a detailed analysis of the quarterly data for Black Rose Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 83.98 Cr.. The value appears strong and on an upward trend. It has increased from 59.85 Cr. (Jun 2025) to 83.98 Cr., marking an increase of 24.13 Cr..
- For Expenses, as of Sep 2025, the value is 76.77 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 53.99 Cr. (Jun 2025) to 76.77 Cr., marking an increase of 22.78 Cr..
- For Operating Profit, as of Sep 2025, the value is 7.21 Cr.. The value appears strong and on an upward trend. It has increased from 5.86 Cr. (Jun 2025) to 7.21 Cr., marking an increase of 1.35 Cr..
- For OPM %, as of Sep 2025, the value is 8.59%. The value appears to be declining and may need further review. It has decreased from 9.79% (Jun 2025) to 8.59%, marking a decrease of 1.20%.
- For Other Income, as of Sep 2025, the value is 0.33 Cr.. The value appears to be declining and may need further review. It has decreased from 0.99 Cr. (Jun 2025) to 0.33 Cr., marking a decrease of 0.66 Cr..
- For Interest, as of Sep 2025, the value is 0.51 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.21 Cr. (Jun 2025) to 0.51 Cr., marking an increase of 0.30 Cr..
- For Depreciation, as of Sep 2025, the value is 0.95 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.90 Cr. (Jun 2025) to 0.95 Cr., marking an increase of 0.05 Cr..
- For Profit before tax, as of Sep 2025, the value is 6.08 Cr.. The value appears strong and on an upward trend. It has increased from 5.74 Cr. (Jun 2025) to 6.08 Cr., marking an increase of 0.34 Cr..
- For Tax %, as of Sep 2025, the value is 27.30%. The value appears to be increasing, which may not be favorable. It has increased from 27.00% (Jun 2025) to 27.30%, marking an increase of 0.30%.
- For Net Profit, as of Sep 2025, the value is 4.43 Cr.. The value appears strong and on an upward trend. It has increased from 4.19 Cr. (Jun 2025) to 4.43 Cr., marking an increase of 0.24 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.87. The value appears strong and on an upward trend. It has increased from 0.82 (Jun 2025) to 0.87, marking an increase of 0.05.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:03 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 115 | 196 | 177 | 242 | 298 | 309 | 373 | 380 | 488 | 430 | 380 | 391 | 313 |
| Expenses | 113 | 189 | 168 | 227 | 276 | 284 | 340 | 339 | 442 | 416 | 352 | 362 | 284 |
| Operating Profit | 2 | 7 | 10 | 15 | 22 | 24 | 33 | 40 | 46 | 14 | 28 | 29 | 29 |
| OPM % | 2% | 3% | 5% | 6% | 7% | 8% | 9% | 11% | 9% | 3% | 7% | 8% | 9% |
| Other Income | 1 | 1 | 1 | 1 | 1 | 1 | -0 | 1 | 1 | 2 | 5 | 3 | 3 |
| Interest | 3 | 5 | 5 | 5 | 4 | 4 | 3 | 2 | 1 | 2 | 1 | 1 | 1 |
| Depreciation | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | -2 | -1 | 2 | 8 | 16 | 19 | 27 | 37 | 43 | 11 | 29 | 28 | 27 |
| Tax % | 11% | -177% | 35% | 34% | 27% | 28% | 24% | 25% | 26% | 28% | 26% | 26% | |
| Net Profit | -3 | 1 | 2 | 5 | 12 | 14 | 21 | 27 | 32 | 8 | 21 | 21 | 20 |
| EPS in Rs | -0.53 | 0.10 | 0.32 | 0.98 | 2.30 | 2.72 | 4.05 | 5.38 | 6.25 | 1.55 | 4.16 | 4.11 | 3.95 |
| Dividend Payout % | 0% | 0% | 0% | 10% | 7% | 11% | 9% | 8% | 12% | 35% | 16% | 77% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 133.33% | 100.00% | 150.00% | 140.00% | 16.67% | 50.00% | 28.57% | 18.52% | -75.00% | 162.50% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -33.33% | 50.00% | -10.00% | -123.33% | 33.33% | -21.43% | -10.05% | -93.52% | 237.50% | -162.50% |
Black Rose Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 1% |
| 3 Years: | -7% |
| TTM: | -10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 43% |
| 5 Years: | 0% |
| 3 Years: | -13% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | -5% |
| 3 Years: | -20% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 18% |
| 3 Years: | 12% |
| Last Year: | 14% |
Last Updated: September 5, 2025, 2:41 pm
Balance Sheet
Last Updated: December 4, 2025, 2:32 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 14 | 14 | 16 | 20 | 30 | 43 | 62 | 88 | 117 | 122 | 140 | 148 | 150 |
| Borrowings | 37 | 42 | 42 | 42 | 35 | 30 | 23 | 17 | 14 | 5 | 4 | 11 | 8 |
| Other Liabilities | 34 | 30 | 22 | 42 | 34 | 31 | 51 | 37 | 40 | 30 | 43 | 50 | 50 |
| Total Liabilities | 90 | 92 | 84 | 109 | 105 | 109 | 141 | 147 | 176 | 162 | 193 | 214 | 213 |
| Fixed Assets | 42 | 41 | 38 | 36 | 34 | 33 | 37 | 35 | 37 | 40 | 41 | 39 | 46 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 7 | 8 | 8 | 7 | 9 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 0 | 10 |
| Other Assets | 48 | 51 | 46 | 73 | 71 | 76 | 102 | 105 | 130 | 114 | 132 | 166 | 152 |
| Total Assets | 90 | 92 | 84 | 109 | 105 | 109 | 141 | 147 | 176 | 162 | 193 | 214 | 213 |
Below is a detailed analysis of the balance sheet data for Black Rose Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Reserves, as of Sep 2025, the value is 150.00 Cr.. The value appears strong and on an upward trend. It has increased from 148.00 Cr. (Mar 2025) to 150.00 Cr., marking an increase of 2.00 Cr..
- For Borrowings, as of Sep 2025, the value is 8.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 11.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 3.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 50.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 50.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 213.00 Cr.. The value appears to be improving (decreasing). It has decreased from 214.00 Cr. (Mar 2025) to 213.00 Cr., marking a decrease of 1.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 39.00 Cr. (Mar 2025) to 46.00 Cr., marking an increase of 7.00 Cr..
- For CWIP, as of Sep 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 3.00 Cr..
- For Investments, as of Sep 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 10.00 Cr..
- For Other Assets, as of Sep 2025, the value is 152.00 Cr.. The value appears to be declining and may need further review. It has decreased from 166.00 Cr. (Mar 2025) to 152.00 Cr., marking a decrease of 14.00 Cr..
- For Total Assets, as of Sep 2025, the value is 213.00 Cr.. The value appears to be declining and may need further review. It has decreased from 214.00 Cr. (Mar 2025) to 213.00 Cr., marking a decrease of 1.00 Cr..
Notably, the Reserves (150.00 Cr.) exceed the Borrowings (8.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -35.00 | -35.00 | -32.00 | -27.00 | -13.00 | -6.00 | 10.00 | 23.00 | 32.00 | 9.00 | 24.00 | 18.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 71 | 52 | 47 | 52 | 42 | 33 | 47 | 42 | 50 | 50 | 64 | 63 |
| Inventory Days | 66 | 32 | 35 | 43 | 37 | 46 | 45 | 53 | 41 | 28 | 44 | 81 |
| Days Payable | 102 | 57 | 41 | 59 | 38 | 34 | 52 | 34 | 28 | 20 | 40 | 45 |
| Cash Conversion Cycle | 34 | 28 | 41 | 37 | 41 | 45 | 40 | 61 | 63 | 58 | 69 | 99 |
| Working Capital Days | -17 | -3 | 4 | 11 | 16 | 28 | 29 | 48 | 53 | 54 | 67 | 93 |
| ROCE % | 1% | 8% | 12% | 19% | 29% | 31% | 38% | 38% | 36% | 10% | 21% | 19% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 4.11 | 4.16 | 1.55 | 6.25 | 5.38 |
| Diluted EPS (Rs.) | 4.11 | 4.16 | 1.55 | 6.25 | 5.38 |
| Cash EPS (Rs.) | 4.72 | 4.75 | 2.15 | 6.77 | 5.89 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 29.97 | 28.45 | 24.92 | 23.99 | 18.23 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 29.97 | 28.45 | 24.92 | 23.99 | 18.23 |
| Revenue From Operations / Share (Rs.) | 76.71 | 74.59 | 84.40 | 95.66 | 74.47 |
| PBDIT / Share (Rs.) | 6.42 | 6.40 | 3.10 | 9.12 | 7.96 |
| PBIT / Share (Rs.) | 5.80 | 5.81 | 2.51 | 8.60 | 7.45 |
| PBT / Share (Rs.) | 5.56 | 5.60 | 2.15 | 8.43 | 7.21 |
| Net Profit / Share (Rs.) | 4.11 | 4.16 | 1.55 | 6.25 | 5.38 |
| NP After MI And SOA / Share (Rs.) | 4.11 | 4.16 | 1.55 | 6.25 | 5.38 |
| PBDIT Margin (%) | 8.36 | 8.58 | 3.67 | 9.53 | 10.68 |
| PBIT Margin (%) | 7.56 | 7.79 | 2.97 | 8.99 | 10.00 |
| PBT Margin (%) | 7.24 | 7.51 | 2.54 | 8.81 | 9.68 |
| Net Profit Margin (%) | 5.35 | 5.58 | 1.83 | 6.53 | 7.22 |
| NP After MI And SOA Margin (%) | 5.35 | 5.58 | 1.83 | 6.53 | 7.22 |
| Return on Networth / Equity (%) | 13.70 | 14.63 | 6.23 | 26.07 | 29.51 |
| Return on Capital Employeed (%) | 18.62 | 19.54 | 9.51 | 33.79 | 37.87 |
| Return On Assets (%) | 9.77 | 11.02 | 4.88 | 18.15 | 18.66 |
| Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 |
| Total Debt / Equity (X) | 0.07 | 0.02 | 0.03 | 0.11 | 0.17 |
| Asset Turnover Ratio (%) | 1.92 | 2.15 | 2.55 | 2.17 | 1.66 |
| Current Ratio (X) | 2.97 | 3.48 | 4.04 | 2.83 | 2.24 |
| Quick Ratio (X) | 1.68 | 2.54 | 2.98 | 1.82 | 1.27 |
| Inventory Turnover Ratio (X) | 7.12 | 11.20 | 1.50 | 1.53 | 0.99 |
| Dividend Payout Ratio (NP) (%) | 64.52 | 13.21 | 48.30 | 7.19 | 6.50 |
| Dividend Payout Ratio (CP) (%) | 56.10 | 11.57 | 34.91 | 6.64 | 5.94 |
| Earning Retention Ratio (%) | 35.48 | 86.79 | 51.70 | 92.81 | 93.50 |
| Cash Earning Retention Ratio (%) | 43.90 | 88.43 | 65.09 | 93.36 | 94.06 |
| Interest Coverage Ratio (X) | 32.70 | 30.57 | 8.61 | 52.25 | 33.69 |
| Interest Coverage Ratio (Post Tax) (X) | 22.17 | 20.87 | 5.31 | 36.84 | 23.79 |
| Enterprise Value (Cr.) | 457.39 | 609.04 | 526.75 | 997.89 | 894.77 |
| EV / Net Operating Revenue (X) | 1.17 | 1.60 | 1.22 | 2.05 | 2.36 |
| EV / EBITDA (X) | 13.97 | 18.65 | 33.29 | 21.46 | 22.05 |
| MarketCap / Net Operating Revenue (X) | 1.16 | 1.64 | 1.26 | 2.04 | 2.33 |
| Retention Ratios (%) | 35.47 | 86.78 | 51.69 | 92.80 | 93.49 |
| Price / BV (X) | 2.98 | 4.30 | 4.26 | 8.15 | 9.54 |
| Price / Net Operating Revenue (X) | 1.16 | 1.64 | 1.26 | 2.04 | 2.33 |
| EarningsYield | 0.04 | 0.03 | 0.01 | 0.03 | 0.03 |
After reviewing the key financial ratios for Black Rose Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 5. It has decreased from 4.16 (Mar 24) to 4.11, marking a decrease of 0.05.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 5. It has decreased from 4.16 (Mar 24) to 4.11, marking a decrease of 0.05.
- For Cash EPS (Rs.), as of Mar 25, the value is 4.72. This value is within the healthy range. It has decreased from 4.75 (Mar 24) to 4.72, marking a decrease of 0.03.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.97. It has increased from 28.45 (Mar 24) to 29.97, marking an increase of 1.52.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.97. It has increased from 28.45 (Mar 24) to 29.97, marking an increase of 1.52.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 76.71. It has increased from 74.59 (Mar 24) to 76.71, marking an increase of 2.12.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 6.42. This value is within the healthy range. It has increased from 6.40 (Mar 24) to 6.42, marking an increase of 0.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.80. This value is within the healthy range. It has decreased from 5.81 (Mar 24) to 5.80, marking a decrease of 0.01.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.56. This value is within the healthy range. It has decreased from 5.60 (Mar 24) to 5.56, marking a decrease of 0.04.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 4.11. This value is within the healthy range. It has decreased from 4.16 (Mar 24) to 4.11, marking a decrease of 0.05.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.11. This value is within the healthy range. It has decreased from 4.16 (Mar 24) to 4.11, marking a decrease of 0.05.
- For PBDIT Margin (%), as of Mar 25, the value is 8.36. This value is below the healthy minimum of 10. It has decreased from 8.58 (Mar 24) to 8.36, marking a decrease of 0.22.
- For PBIT Margin (%), as of Mar 25, the value is 7.56. This value is below the healthy minimum of 10. It has decreased from 7.79 (Mar 24) to 7.56, marking a decrease of 0.23.
- For PBT Margin (%), as of Mar 25, the value is 7.24. This value is below the healthy minimum of 10. It has decreased from 7.51 (Mar 24) to 7.24, marking a decrease of 0.27.
- For Net Profit Margin (%), as of Mar 25, the value is 5.35. This value is within the healthy range. It has decreased from 5.58 (Mar 24) to 5.35, marking a decrease of 0.23.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.35. This value is below the healthy minimum of 8. It has decreased from 5.58 (Mar 24) to 5.35, marking a decrease of 0.23.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.70. This value is below the healthy minimum of 15. It has decreased from 14.63 (Mar 24) to 13.70, marking a decrease of 0.93.
- For Return on Capital Employeed (%), as of Mar 25, the value is 18.62. This value is within the healthy range. It has decreased from 19.54 (Mar 24) to 18.62, marking a decrease of 0.92.
- For Return On Assets (%), as of Mar 25, the value is 9.77. This value is within the healthy range. It has decreased from 11.02 (Mar 24) to 9.77, marking a decrease of 1.25.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.07. This value is within the healthy range. It has increased from 0.02 (Mar 24) to 0.07, marking an increase of 0.05.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.92. It has decreased from 2.15 (Mar 24) to 1.92, marking a decrease of 0.23.
- For Current Ratio (X), as of Mar 25, the value is 2.97. This value is within the healthy range. It has decreased from 3.48 (Mar 24) to 2.97, marking a decrease of 0.51.
- For Quick Ratio (X), as of Mar 25, the value is 1.68. This value is within the healthy range. It has decreased from 2.54 (Mar 24) to 1.68, marking a decrease of 0.86.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.12. This value is within the healthy range. It has decreased from 11.20 (Mar 24) to 7.12, marking a decrease of 4.08.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 64.52. This value exceeds the healthy maximum of 50. It has increased from 13.21 (Mar 24) to 64.52, marking an increase of 51.31.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 56.10. This value exceeds the healthy maximum of 50. It has increased from 11.57 (Mar 24) to 56.10, marking an increase of 44.53.
- For Earning Retention Ratio (%), as of Mar 25, the value is 35.48. This value is below the healthy minimum of 40. It has decreased from 86.79 (Mar 24) to 35.48, marking a decrease of 51.31.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 43.90. This value is within the healthy range. It has decreased from 88.43 (Mar 24) to 43.90, marking a decrease of 44.53.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 32.70. This value is within the healthy range. It has increased from 30.57 (Mar 24) to 32.70, marking an increase of 2.13.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 22.17. This value is within the healthy range. It has increased from 20.87 (Mar 24) to 22.17, marking an increase of 1.30.
- For Enterprise Value (Cr.), as of Mar 25, the value is 457.39. It has decreased from 609.04 (Mar 24) to 457.39, marking a decrease of 151.65.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has decreased from 1.60 (Mar 24) to 1.17, marking a decrease of 0.43.
- For EV / EBITDA (X), as of Mar 25, the value is 13.97. This value is within the healthy range. It has decreased from 18.65 (Mar 24) to 13.97, marking a decrease of 4.68.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.64 (Mar 24) to 1.16, marking a decrease of 0.48.
- For Retention Ratios (%), as of Mar 25, the value is 35.47. This value is within the healthy range. It has decreased from 86.78 (Mar 24) to 35.47, marking a decrease of 51.31.
- For Price / BV (X), as of Mar 25, the value is 2.98. This value is within the healthy range. It has decreased from 4.30 (Mar 24) to 2.98, marking a decrease of 1.32.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.64 (Mar 24) to 1.16, marking a decrease of 0.48.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Black Rose Industries Ltd:
- Net Profit Margin: 5.35%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 18.62% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.7% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 22.17
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.68
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 24.1 (Industry average Stock P/E: 68.6)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.07
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5.35%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | 145-A, Mittal Tower, Mumbai Maharashtra 400021 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anup Jatia | Non Executive Chairperson |
| Mrs. Shruti Jatia | Whole Time Director |
| Mr. Ambarish Daga | Whole Time Director |
| Mr. Rishabh Saraf | Ind. Non-Executive Director |
| Mr. Abhishek Murarka | Ind. Non-Executive Director |
| Mrs. Deepa Poncha | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Black Rose Industries Ltd?
Black Rose Industries Ltd's intrinsic value (as of 30 December 2025) is 84.41 which is 12.16% lower the current market price of 96.10, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 490 Cr. market cap, FY2025-2026 high/low of 138/87.0, reserves of ₹150 Cr, and liabilities of 213 Cr.
What is the Market Cap of Black Rose Industries Ltd?
The Market Cap of Black Rose Industries Ltd is 490 Cr..
What is the current Stock Price of Black Rose Industries Ltd as on 30 December 2025?
The current stock price of Black Rose Industries Ltd as on 30 December 2025 is 96.1.
What is the High / Low of Black Rose Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Black Rose Industries Ltd stocks is 138/87.0.
What is the Stock P/E of Black Rose Industries Ltd?
The Stock P/E of Black Rose Industries Ltd is 24.1.
What is the Book Value of Black Rose Industries Ltd?
The Book Value of Black Rose Industries Ltd is 30.5.
What is the Dividend Yield of Black Rose Industries Ltd?
The Dividend Yield of Black Rose Industries Ltd is 1.09 %.
What is the ROCE of Black Rose Industries Ltd?
The ROCE of Black Rose Industries Ltd is 19.0 %.
What is the ROE of Black Rose Industries Ltd?
The ROE of Black Rose Industries Ltd is 14.2 %.
What is the Face Value of Black Rose Industries Ltd?
The Face Value of Black Rose Industries Ltd is 1.00.